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Nitric Oxide Inactivates Rat Hepatic Methionine
Adenosyltransferase In Vivo by S-Nitrosylation
FE´LIX RUIZ, FERNANDO J. CORRALES, CARMEN MIQUEO, AND JOSE´ M. MATO
We investigated the mechanism of nitric oxide (NO)
action on hepatic methionine adenosyltransferase (MAT)
activity using S-nitrosoglutathione (GSNO) as NO donor.
Hepatic MAT plays an essential role in the metabolism of
methionine, converting this amino acid into S-adenosylme-
thionine. Hepatic MAT exists in two oligomeric states: as a
tetramer (MAT I) and as a dimer (MAT III) of the same
subunit. This subunit contains 10 cysteine residues. In
MAT I, S-nitrosylation of 1 thiol residue per subunit was
associated with a marked inactivation of the enzyme (about
70%) that was reversed by glutathione (GSH). In MAT III,
S-nitrosylation of 3 thiol residues per subunit led to a
similar inactivation of the enzyme, which was also reversed
by GSH. Incubation of isolated rat hepatocytes with
S-nitrosoglutathione monoethyl ester (EGSNO), a NO do-
nor permeable through the cellular membrane, induced a
dose-dependent inactivation of MAT that was reversed by
removing the NO donor from the cell suspension. MAT,
purified from isolated rat hepatocytes, contained S-
nitrosothiol groups and the addition of increasing concentra-
tions of EGSNO to the hepatocyte suspension led to a
progressive S-nitrosylation of the enzyme. Removal of the
NO donor from the incubation media resulted in loss of
most NO groups associated to the enzyme. Finally, induc-
tion in rats of the production of NO, by the administration
of bacterial lipopolysaccharide (LPS), induced a fivefold
increase in the S-nitrosylation of hepatic MAT, which led to
a marked inactivation of the enzyme. Thus, the activity of
liver MAT appears to be regulated in vivo by S-nitrosylation.
(HEPATOLOGY 1998;28:1051-1057.)
Nitric oxide (NO) (nitrogen monoxide) exerts its direct
effects by covalently modifying or oxidizing critical thiols or
transition metals in proteins.1,2 Consequently, the function of
an increasing number of proteins has been demonstrated to
be regulated in vitro by S-nitrosylation.1,2 However, there is
still little evidence showing the regulation of enzyme activity
by reversible S-nitrosylation in vivo or in intact cells.1,2 NO
may be a physiological regulator of liver methionine adeno-
syltransferase (MAT), the enzyme that converts methionine,
in the presence of adenosine triphosphate (ATP) into
S-adenosylmethionine.3,4 In mammals, it is now established
that two genes encoding homologous, but different, MAT
protein subunits are present.5-7 One gene (MAT1A), ex-
pressed in the liver only, encodes a subunit found in two
native MAT isoforms, which are either a homodimer (MAT
III) or a homotetramer (MAT I) of this single subunit. The
second gene (MAT2A) is expressed in all other mammalian
tissues including fetal liver. The subunit it encodes is found
in a native MAT isoform known as MAT II.
We have previously demonstrated that increased NO
production in the liver, during septic shock or hypoxia, led to
the inactivation of hepatic MAT, whereas inhibition of NO
synthase, by NG-nitro-L-arginine-methylester, resulted in mark-
edly decreased hepatic MAT inactivation in response to
hypoxia.3,4 Moreover, the activity of MAT I and MAT III,
purified from rat liver, was inactivated by incubation with NO
donors (3-morpholinosydnonimine and S-nitroso-N-acetyl-
penicillamine).3 This inactivation of hepatic MAT by NO was
reversed by millimolar amounts of glutathione (GSH).3 The
hepatic MAT subunit contains 10 cysteine residues.6 We have
also demonstrated that the enzymatic activity of a hepatic
MAT mutant, in which the cysteine residue 121 was replaced
by a serine, was resistant to NO inactivation.3
These results strongly suggest that hepatic MAT is regu-
lated by reversible S-nitrosylation, but no direct evidence
showing S-nitrosylation of MAT is yet available. However,
although large amounts of NO (micromolar) are produced by
the liver under pathological conditions (tumor necrosis
factor a, interleukin-1, interferon gamma, bacterial lipopoly-
saccharide [LPS]),8 the finding that physiological amounts
(millimolar) of GSH reversed the action of NO on MAT
activity3 raises doubts about how NO would affect the activity
of MAT in vivo. In this study, we demonstrate that liver MAT is
S-nitrosylated both in vitro and in vivo and that LPS-mediated
hepatic MAT inactivation involves the S-nitrosylation of the
enzyme.
MATERIALS AND METHODS
Materials. Protease inhibitors (phenylmethylsulfonyl fluoride and
benzamide), ATP, L-methionine, DL-dithiothreitol (DTT), LPS, and
GSH were obtained from Sigma (St. Louis, MO); [2-3H] ATP (25.5
Ci/mmol) was from Amersham (Little Chalfont, England). The
cation exchanger, AG 50W-X4 (200 to 400 mesh), was from Bio-Rad
Abbreviations: MAT, methionine adenosyltransferase; ATP, adenosine triphosphate;
GSH, reduced glutathione; LPS, lipopolysaccharide; DTT, dithiothreitol; EGSNO,
S-nitrosoglutathione monoethyl ester; EDTA, ethylenediaminetetraacetic acid; GSNO,
S-nitrosoglutathione; GSSG, oxidized glutathione; EGSH, glutathione monoethyl ester;
SDS-PAGE, sodium dodecyl sulfate–polyacrylamide gel electrophoresis; SNO, S-
nitrosothiol; NOx, nitrite and nitrate.
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Laboratories (Richmond, CA). DEAE fast-flow, phenyl Sepharose
fast-flow, blue Sepharose fast-flow, Sephacryl S-300, DEAE sephacel,
and phenyl Sepharose were from Pharmacia (Uppsala, Sweden).
2-Mercaptoethanol was from Merck AG (Darmstadt, Germany), and
scintillation fluid Optiphase Hisafe 3 was from Wallac (Loughbor-
ough, UK). High-performance liquid chromatography column Ami-
nopropyl Spherisorb for glutathione determination was from Waters
(Bedford, MA).
Isolation and Incubation of Hepatocytes. Hepatocytes were isolated
from normally fed Wistar albino rats (250 g) as described by Castan˜o
et al.9 Isolated hepatocytes were incubated as follows: 1 to 4 mL of
cell suspension (2 3 106 cells/mL) were shaken in stopped 20-mL
vials at 37°C in the presence of 10 mmol/L glucose. The gas phase
was 95% O2 and 5% CO2. After 30 minutes of preincubation,
S-nitrosoglutathione monoethyl ester (EGSNO) or buffer were
added, and cells were incubated for the desired periods of time. The
suspension of hepatocytes was poured after the indicated periods
into precooled, centrifuged tubes and immediately centrifuged for
10 seconds. Cells were then washed twice in phosphate-buffered
saline buffer before being homogenized by 3 cycles of freezing and
thawing in 10 mmol/L Tris, 0.3 mol/L sucrose, and 1 mmol/L
ethylene glycol-bis(b-aminoethyl ether)-N,N-tetraacetic acid (EGTA)
(pH 7.5) containing 0.1% PMSF and 0.1% benzamidine. Cytosol was
obtained by centrifugation at 100,000g at 4°C. The amount of
hepatic MAT protein was determined by Western blot analysis as
previously described.10 Cell viability was determined before and
after the incubation by the Trypan blue exclusion test. Only cell
preparations with a viability greater than 85% were used. All animals
were treated humanely, and study protocols were in compliance with
our institution’s guidelines for the use of laboratory animals.
LPS Treatment. Animals received intraperitoneal injections of LPS
(20 mg/kg) or saline at 8 AM as previously reported.3 Samples were
collected 6 hours after the administration of LPS. Liver samples were
removed and quickly freeze-clamped in liquid nitrogen. Livers were
homogenized in 4 volumes of 10 mmol/L Tris/HCl (pH 7.5),
containing 0.3 mol/L sucrose, 1 mmol/L EGTA, 0.1% phenylmethyl-
sulfonyl fluoride, and 0.1% benzamidine. The homogenate was
centrifuged for 20 minutes at 10,000g at 4°C; the supernatant was
again centrifuged for 1 hour at 100,000g. Total MAT activity and
MAT S-nitrosylation were analyzed in this last supernatant as
described below.
Purification of MAT. MATI and MATIII were purified from the liver
of 250-g Wistar albino rats according to the procedure previously
described,11 in the presence of protease inhibitors and reducing
agents. All purified enzymes were stored at 270°C in 10 mmol/L
HEPES, 10 mmol/L MgSO4, and 1 mmol/L ethylenediaminetetraace-
tic acid (EDTA) (pH 7.5) (buffer A) containing 20% glycerol and 10
mmol/L DTT. Recombinant liver MAT forms were overexpressed in
Escherichia coli and purified according to Mingorance et al.12
MAT Activity Measurements. MAT activity assays were performed
according to Cabrero et al.13 at saturating concentrations of the
substrates, 5 mmol/L methionine and 5 mmol/L ATP, in the absence
of any reducing agent. Cytosol extracts, prepared as described
above, were used directly for the enzymatic assay. Glycerol and DTT
were removed from purified protein preparations by chromatogra-
phy on a 1-mL DEAE column immediately before being used for
activity measurements. Incubation with S-nitrosoglutathione (GSNO)
was performed at 37°C for 15 minutes, and then enzymatic activity
was assayed.
GSH and Oxidized Glutathione Measurements. GSH and oxidized
glutathione (GSSG) content was measured by high-performance
liquid chromatography according to the method described by Reed
et al.14 Briefly, 200 µL of the cytosolic fraction obtained as indicated
above was immediately derivatized using 1-fluoro-2,4-dinitroben-
zene. Samples were then chromatographed on a 3-aminopropyl-
Spherisorb, 20 cm 3 4.6-mm, 5-µm HPLC column, equilibrated in
80% methanol. Elution was performed with 0.5 mol/L sodium
acetate in 64% methanol and followed at 365 nm. Analysis of the
chromatogram was performed with a Beckman System Gold soft-
ware.
Preparation of GSNO and EGSNO. GSNO and EGSNO were pre-
pared according to the method of Saville.15 Briefly, equimolar
concentrations of an aqueous solution of NaNO2 and a freshly
prepared GSH or EGSH solution in 250 mmol/L HCl and 0.1 mol/L
EDTA (pH 1.5) were mixed. The resulting mixture was incubated at
room temperature for 5 minutes and then neutralized with NaOH.
Cytosolic Nitrite and Nitrate Measurements. Nitrite and nitrate were
measured using a NOA 280 chemiluminescence detector following
the method recommended by Sievers.16 Cytosolic nitrite and nitrate
were reduced to NO by incubation with glacial acetic acid contain-
ing 350 mmol/L INa or 1 N HCl containing 50 mmol/L VCl3,
respectively. The resulting NO was measured by the chemilumin-
escence derived from its reaction with ozone, according with the
following two reactions:
NO 1 O3 = NO2* 1 O2; NO2* = NO2 1 hn
Determination of MAT S-Nitrosylation. Samples of purified MAT
protein (0.2 mg/mL) were incubated with GSNO at 37°C for 15
minutes in the absence of any reducing agent. To remove the excess
of GSNO, 200 µL of a DEAE resin equilibrated in 10 mmol/L HEPES,
10 mmol/L MgSO4, and 1 mmol/L EDTA (pH 7.5) (buffer A) were
added to the assay mixture. The resin was washed twice with 10
volumes of buffer A with 100 mmol/L KCL (pH 7.5) before eluting
the protein with the same buffer containing 200 mmol/L KCl.
S-Nitrosylated proteins were incubated with 2.2 mmol/L HgCl2, and
the amount of NO released was measured using a Sievers NOA 280
nitric oxide analyzer.16 Standard curves were generated with known
concentrations of GSNO. To measure the S-nitrosylation of MAT III
in intact hepatocytes, the protein was purified from the cytosolic
fraction of 4 mL of cell suspension (2 3 106 cells/mL) after
incubation with the indicated concentrations of EGSNO. The
cytosol was loaded into a 2-mL column of DEAE sephacel equili-
brated in buffer A. The column was washed with 10 column
volumes of buffer A containing 100 mmol/L KCl before elution with
2 mL of buffer A containing 200 mmol/L KCl. The enzyme was then
chromatographed in a 1-mL Phenyl Sepharose column equilibrated
in buffer A with 200 mmol/L KCl. The column was washed with 10
column volumes of buffer A with 200 mmol/L KCl, and then with 10
volumes of 10 mmol/l HEPES and 1 mmol/L EDTA (pH 7.5).
Dimethyl sulfoxide is commonly used to elute MAT III from the
phenyl Sepharose column.11 Because dimethyl sulfoxide interfered
with the NO detection, the resin containing MAT III protein was
directly incubated with 2.2 mmol/L HgCl2, and the amount of NO
released was measured using a Sievers NOA 280 nitric oxide
analyzer. The purity of MAT III, eluted from the phenyl Sepharose
column with 1 mL buffer A containing 50% dimethyl sulfoxide, was
tested by sodium dodecyl sulfate–polyacrylamide gel electrophoresis
(SDS-PAGE).17 To determine the recovery of S-nitrosylated MAT III
purified by this procedure, a sample of MAT III purified from rat
liver was reacted in vitro with 100 µmol/L GSNO as described above,
and the amount of S-nitrosothiols (SNO) groups incorporated per
microgram of protein determined in an aliquot. The rest of the
S-nitrosylated enzyme was added to a freshly prepared homogenate
of hepatocytes. MAT III was then purified and the amount of SNO
groups determined as mentioned above. The recovery of SNO
groups incorporated into MAT III was between 80% to 90%. To
measure the S-nitrosylation of MAT III in liver, the protein was
purified from the cytosolic fraction of about 0.2 g of liver and the
amount of SNO groups incorporated per milligram of protein
determined as described above.
RESULTS
S-Nitrosylation and Inactivation of Purified Rat Liver MAT by
GSNO. S-Nitrosylation of purified rat liver MAT I and MAT III
was directly measured after reaction with GSNO, a low-mass
NO donor,18 under conditions that led to inactivation of the
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enzyme (Fig. 1). In MAT I, 100 µmol/L GSNO induced the
S-nitrosylation of about 1 thiol residue per subunit and led to
70% inactivation of the enzyme. In MAT III, 100 µmol/L
GSNO also induced 70% inactivation, and this effect was
accompanied by the S-nitrosylation of about 3 thiol residues
per enzyme subunit. In the presence of 50 µmol/L GSNO, the
inactivation of both MAT I and MAT III was about 50%. We
have previously demonstrated that substitution of cysteine
121 by a serine residue prevented hepatic MAT inactivation
by 3-morpholinosydnonimine (a NO donor) and OH radi-
cal.3,19 As expected, the addition of 50 µmol/L GSNO to the
wild-type recombinant enzyme, a mixture of MAT I and MAT
III,12 led to 50% reduction of the enzyme activity, whereas the
substitution of cysteine 121 by a serine residue prevented the
ability of GSNO to inactivate liver MAT (data not shown).
Similarly, whereas incubation of the wild-type enzyme with
100 µmol/L GSNO led to the S-nitrosylation of 2.2 6 0.2 thiol
residues per subunit, in the mutant enzyme, only 1.2 6 0.1
thiol residues per subunit were S-nitrosylated. S-Nitrosyla-
tion of up to 8 thiol residues per enzyme subunit was observed,
with both MAT I and MAT III, at saturating concentrations of
GSNO (Fig. 1). Under these conditions, both isoforms of liver
MAT were almost completely inactivated.
The effect of GSNO on hepatic MAT activity was reversible.
Thus, addition of 2 mmol/L GSH to purified MAT I or MAT III
preincubated with 100 µmol/L GSNO (to reach an inactiva-
tion of about 70%) returned the activity to that of the
untreated enzymes (Table 1). These results agree with previ-
ous findings showing that MAT inactivation by 3-morpholi-
nosydnonimine was reversed by the addition of GSH.3 The
addition of GSH also induced the loss of SNO groups from
purified MAT I and MAT III pretreated with GSNO (Table 1).
Thus, addition of 2 mmol/L GSH to purified MAT I or MAT III
pretreated with 100 µmol/L GSNO resulted in the loss of most
of the NO groups incorporated into the enzymes. These
results indicate that MAT S-nitrosylation is a reversible
process and that conditions that resulted in loss of SNO
groups reversed the inactivation of the enzyme.
MAT activity measurements were performed at saturating
levels of methionine and ATP, the substrates of the reaction,
indicating that GSNO reduced the Vmax of both MAT I and
MAT III. To determine whether GSNO also affected the
affinity of the enzymes for their substrates, kinetics experi-
ments were performed in the presence of 50 µmol/L GSNO
(to reach an inactivation of about 50%). In MAT I, GSNO had
no effect on the apparent S0.5 values for methionine (170
µmol/L) and ATP (190 µmol/L). In contrast, the apparent S0.5
values of MAT III for methionine and ATP increased in the
presence of GSNO from 0.6 mmol/L to 1.4 mmol/L and from
0.9 mmol/L to 1.8 mmol/L, respectively.
S-Nitrosylation and Inactivation of MAT in Isolated Rat Hepato-
cytes and in an In Vivo Model of Septic Shock. GSNO, like GSH, is
not readily permeable through the cell membrane. Conse-
quently, we found that in isolated rat hepatocytes, the
addition of GSNO (up to 10 mmol/L) had little or no effect on
the intracellular concentration of nitrite and nitrate (NOx),
the inactive metabolites of NO (data not shown). Accord-
ingly, GSNO had no effect on MAT activity in isolated rat
hepatocytes (data not shown). EGSH is a well-known perme-
able derivative of GSH, which, upon its entrance to the cell, is
converted into GSH and ethanol.20 We therefore tested the
ability of EGSNO, the S-nitroso derivative of EGSH, to
increase the intracellular concentration of NOx in isolated rat
hepatocytes. We first studied the potency of EGSNO as a NO
donor in vitro using MAT I and MAT III purified from rat liver,
and observed that this molecule was as potent as GSNO in
inducing MAT S-nitrosylation and inactivation (data not
shown). The addition of EGSNO to isolated rat hepatocytes
FIG. 1. Effect of GSNO on hepatic MAT S-nitrosylation and inactivation.
Purified liver MAT I (A) and MAT III (B) were reacted with various
concentrations of GSNO and the formation of nitrosothiol (SNO) groups
(s), and the activity of the enzyme (d) was determined as described in
Materials and Methods. Values are expressed as means 6 SEM of three
experiments in triplicate using different preparations of the enzyme. One
hundred percent activity was 39 6 7 pmol/min/mg protein and 29 6 3
pmol/min/mg protein for MAT I and MAT III, respectively.
TABLE 1. Reversion by GSH of GSNO-Induced MAT Inactivation
and S-Nitrosylation
Enzyme
Activity
(% of control)
S-Nitrosylation
(mol SNO/mol subunit)
2GSH 1GSH 2GSH 1GSH
MAT I
(100 µmol/L GSNO) 25 6 4.5 102 6 5.4* 1.02 6 0.19 0.20 6 0.06*
MAT III
(100 µmol/L GSNO) 32 6 5.3 99 6 4.6* 2.39 6 0.20 0.24 6 0.07*
NOTE. Purified MAT I and MAT III were incubated in the absence or
presence of 100 µmol/L GSNO for 15 minutes. Samples were then incubated
in the absence or presence of 2 mmol/L GSH for another 15 minutes. At the
end of this period, MAT activity and S-nitrosylation were determined. Values
are the means 6 SEM of three independent experiments in triplicate.
*Values significantly different from the corresponding value in the absence
of GSH (P , .005).
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induced a dose-dependent intracellular accumulation of
NOx, which led to a progressive MAT inactivation (Fig. 2A).
The addition of 5 mmol/L EGSNO to the cell suspension
induced an elevation of NOx levels of about eightfold, which
led to 70% inactivation of MAT (Fig. 2A). Up to a concentra-
tion of 5 mmol/L EGSNO, added to the cell suspension, this
molecule had no effect on the intracellular GSH levels (about
5 mmol/L) or in the ratio GSH/GSSG (about 100) (data not
shown). However, at 10 mmol/L EGSNO, NOx levels in-
creased about 25-fold (Fig. 2A), and the ratio of GSH/GSSG
decreased to reach a value of about 10 (data not shown). The
addition of 5 mmol/L EGSH to isolated rat hepatocytes had
no effect on NOx levels and, as previously described for rat
liver,21 slightly increased MAT activity (data not shown). The
reduction in MAT activity induced by EGSNO was not the
consequence of an increased degradation or release of hepatic
MAT, because no changes in the levels of this enzyme were
detected by Western blotting (Fig. 2B). Moreover, no signifi-
cant lysis of the hepatocytes was observed after incubation
with the various doses of EGSNO mentioned in Fig. 2 (data
not shown).
MAT III can be readily isolated in the absence of DTT in the
buffers used for purification to avoid the loss of SNO groups
in the enzyme, by using the procedure mentioned in Materi-
als and Methods. The enzyme obtained with this protocol had
a purity greater than 90% as judged by SDS-PAGE (Fig. 3B).
On the contrary, no method is yet available that permits the
rapid isolation of MAT I. When MAT I was purified by the
conventional procedure described in Materials and Methods,
the enzyme lost the SNO groups. Therefore, only S-
nitrosylation of MAT III was directly measured in isolated rat
hepatocytes after the addition of various concentrations of
EGSNO to the cell suspension. MAT III purified from isolated
rat hepatocytes contained SNO groups (10 6 3 nmol of SNO
per milligram MAT subunit; about 0.4 sites per MAT subunit)
(Fig. 3A). EGSNO addition to the hepatocyte suspension
induced a dose-dependent S-nitrosylation of MAT III (Fig.
3A). Thus, in the presence of 5 mmol/L EGSNO, the number
of SNO groups incorporated into MAT III increased about
fivefold (about 1.8 sites per MAT subunit), and the addition
of 10 mmol/L EGSNO led to the S-nitrosylation of about 7
thiol groups per MAT subunit (Fig. 3A).
The reversibility of the inactivation of MAT by EGSNO in
isolated hepatocytes was demonstrated by removing the NO
donor from the incubation media and resuspension of the
cells in fresh buffer without EGSNO (Fig. 4A). As mentioned
above, a 60% to 70% inactivation of MAT was observed
within 30 minutes after the addition of 5 mmol/L EGSNO. In
B
FIG. 2. Effect of EGSNO on hepatocyte MAT activity and NOx levels.
Hepatocytes were incubated with various concentrations of EGSNO. (A)
Cytosolic NOx (s) levels and MAT (d) activity were determined after 30
minutes of incubation with the NO donor as described in Materials and
Methods. Values are expressed as means 6 SEM of three independent
experiments in triplicate. (B) Hepatic MAT protein levels were determined by
Western blot analysis in hepatocytes after 30 minutes of incubation in the
presence of EGSNO.
B
FIG. 3. S-Nitrosylation of MAT III isolated from hepatocytes treated with
EGSNO. (A) MAT III was purified from hepatocytes exposed to various
concentrations of EGSNO for 30 minutes, and the extent of S-nitrosylation
was determined as described in Materials and Methods. Values are the
means 6 SEM of nine (0, 2, and 5 mmol/L EGSNO) or three (1 and 10
mmol/L EGSNO) independent experiments in triplicate. Values in the
presence of EGSNO were significantly different from the control (P , .01).
(B) SDS-PAGE analysis of MAT III purified from isolated rat hepatocytes.
Lane 1: migration of the molecular-size markers; lane 2: migration of MAT III
purified as described in Materials and Methods. Molecular weights are
indicated.
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the presence of EGSNO, this inactivation was maintained
during the next 30 minutes. In contrast, removal of EGSNO,
by taking off the incubation media by centrifugation and
resuspension of the cells in fresh buffer without the NO
donor, returned MAT activity close to that of untreated
hepatocytes (Fig. 4A). S-Nitrosylation of MAT III was also
measured after removal of EGSNO from the incubation
media. As shown in Fig. 4B, elimination of the NO donor
from the incubation media returned MAT S-nitrosylation to
values similar to those of the untreated hepatocytes.
In vivo S-nitrosylation of rat liver MAT was also analyzed 7
hours after the intraperitoneal injection of LPS. In agreement
with previous reports,3,22,23 endotoxin administration to rats
resulted in the expression in liver of inducible NO synthase
and in the accumulation in serum of NOx (data not shown).
Liver MAT III purified from control animals contained SNO
groups (5 6 3 nmol of SNO per milligram MAT subunit;
about 0.2 sites per MAT subunit) (Fig. 5). Administration of
LPS to rats induced a fivefold increase in S-nitrosylation of
MAT III (about 1 site per MAT subunit) (Fig. 5). Under the
present conditions, the hepatic concentration of GSH and
GSSG did not change significantly with LPS injection (data
not shown). As previously reported,3 hepatic MAT activity
decreased by about 60% in animals treated with LPS (data not
shown). These results demonstrate that NO inactivates he-
patic MAT in vivo by S-nitrosylation in the presence of
physiological concentrations of GSH.
DISCUSSION
Our previous work implicated NO as a regulator of liver
MAT.3,4 Thus, we have previously demonstrated that in-
creased NO production in the liver, during septic shock or
hypoxia, was associated with the inactivation of hepatic MAT,
whereas inhibition of NO synthase, by NG-nitro-L-arginine-
methylester, resulted in markedly decreased hepatic MAT
inactivation in response to hypoxia.3,4 Moreover, the activity
of MAT I and MAT III, purified from rat liver, was inactivated
by incubation with the NO donors, 3-morpholinosydnon-
imine and S-nitroso-N-acetyl-penicillamine. Finally, elevated
NO production in human cirrhosis, which is suggested by the
finding of increased serum and urine nitrate,24 is associated
with reduced liver MAT activity25,26 and impaired methionine
metabolism.27,28
The present results indicate that NO appears to cause MAT
inactivation by covalent modification by S-nitrosylation of
specific thiol groups. The hepatic MAT subunit contains 10
cysteine residues. In MAT I, 100 µmol/L GSNO induced the
modification of one site per subunit and was associated with
an inactivation of about 70%. This agrees with the finding
that substitution of cysteine 121 by serine, but not of any of
the other nine thiol groups, protected liver MAT from the
inactivation induced by 3-morpholinosydnonimine3 or GSNO.
In MAT III, three SNO groups per enzyme subunit were
formed at 100 µmol/L GSNO, and this was also associated
with the loss of about 70% of the enzyme activity. Because
FIG. 5. Effect of LPS treatment on liver MAT III S-nitrosylation. Hepatic
levels of MAT III S-nitrosylation were determined 7 hours after the
intraperitoneal injection of LPS or saline as described in Materials and
Methods. Values are expressed as means 6 SEM of three independent
experiments in triplicate. The value in the presence of LPS was significantly
different from the control (P , .001).
FIG. 4. Reversion of MAT inactivation and S-nitrosylation induced by
EGSNO in isolated rat hepatocytes. Isolated rat hepatocytes were incubated
in the absence (s) or presence (d) of 5 mmol/L EGSNO for 30 minutes. At
the end of this period, EGSNO was removed from the media by centrifuga-
tion, and, after washing the cells twice, the hepatocytes were resuspended in
fresh media and incubated again for another 30 minutes in the absence (n)
or presence (d) of 5 mmol/L EGSNO. Total MAT activity (A) and MAT III
S-nitrosylation (B) were determined as described in Materials and Methods at
the times indicated in the figure. Values are expressed as means 6 SEM of
three independent experiments in triplicate. Values in the presence of
EGSNO were significantly different from the corresponding values in the
absence of this agent (P , .005).
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MAT I is a tetramer and MAT III is a dimer of the same
subunit, different accessibility to cysteine residues may
account for these differences in S-nitrosylation between both
forms. Thus, cysteine 105, which is in the interaction surface
between dimers,19 may be accessible to S-nitrosylation in
MAT III, but protected in MAT I. The modification of these
additional groups in MAT III might be related to the finding
that S-nitrosylation not only affected the Vmax of this enzyme,
but also its affinity for the substrates, ATP and methionine.
The finding that up to 8 sites per MAT subunit were
S-nitrosylated, at saturating (millimolar) concentrations of
GSNO, agrees with the observation that liver MAT contains
10 cysteine residues per subunit, 2 of which, probably
residues 35 and 67, are forming an intrasubunit disulfide
bridge.29 It is important to point out that GSNO is an
exemplary compound and not necessarily the physiological
nitrosating agent in cells.
Inactivation and S-nitrosylation of purified MAT I and
MAT III by micromolar GSNO was reversed by the addition of
physiological amounts (millimolar) of GSH. This finding
raises doubts about how NO would affect the activity of this
enzyme in vivo. To clarify this point, we studied the effect of
GSNO on MAT activity and S-nitrosylation in isolated rat
hepatocytes. For these studies, we used EGSNO, a derivative
of GSNO that is permeable through the cell membrane. Our
results indicate that a relatively small increase (about five- to
eightfold) in the hepatocyte NO content (measured as the
cellular accumulation of NOx) was associated with a marked
inactivation and S-nitrosylation of MAT. Moreover, removal
of the NO donor from the media resulted in the reactivation
of the enzyme and loss of the SNO groups. Up to a
concentration of 5 mmol/L EGSNO in the incubation media,
no significant changes in the intracellular GSH concentration
or in the GSH/GSSG ratio was measured. The latter is
important because GSSG has been previously shown to
induce the inactivation of MAT I and MAT III purified from
rat liver.11 The present results indicate that S-nitrosylation
and inactivation of hepatic MAT can occur in vivo in the
presence of normal (millimolar) GSH levels. These results
contrast with the observation that 2 mmol/L GSH led to the
loss of NO groups from purified MAT I and MAT III and
restored their activities to normal. The reasons for these
differences between in vivo and in vitro experiments are not
clear. Compartmentalization of GSH, which has been ob-
served in various cell types,30 may account for these differ-
ences.
Alterations of hepatic function have been described during
septic shock,31 a pathological condition triggered by LPS.32 In
sepsis, the liver is a target for LPS and a number of endotoxic
shock effectors, such as proinflammatory cytokines.33 We
have evaluated the effect of LPS on hepatic MAT III S-
nitrosylation. In agreement with previous reports,3,22,23 intra-
peritoneal injection of LPS to rats resulted in the accumula-
tion in serum of NOx and in the inactivation of hepatic MAT.
Moreover, LPS treatment also induced a marked increase in
MAT III S-nitrosylation in the presence of normal levels of
GSH and GSSG. These results indicate that the mechanism by
which LPS induces hepatic MAT inactivation in vivo involves
S-nitrosylation of the enzyme.
We have previously demonstrated that hydrogen peroxide,
via generation of a hydroxyl radical, also inactivates hepatic
MAT by reversibly and covalently oxidizing the same enzyme
site that NO does, i.e., cysteine 121.19 Our findings therefore
indicate that this cysteine residue can serve as a sensor of
both nitrosative and oxidative signals. Cysteine 121 is local-
ized at a ‘‘flexible loop’’ over the active site cleft of MAT.19 We
suggest that NO and OH may regulate MAT activity by fixing
this ‘‘flexible loop’’ in a conformation where the access of ATP
to the active site is impaired. In the resting state, the
hepatocytes may produce small amounts of NO and OH, but
the high intracellular concentration of GSH would protect
cysteine 121 of MAT from being modified. In this state,
hepatic MAT would be fully active and could convert all the
available methionine into S-adenosylmethionine at the ex-
penses of ATP. With hypoxia or septic shock, the hepatic
production of NO and/or OH will be increased, switching
MAT into a less-active conformation by S-nitrosylation or
oxidation of cysteine 121. In this state, the consumption of
ATP by MAT would be reduced. This would contribute to
regulate the hepatic utilization of ATP, and therefore to
prevent nicotinamide adenine dinucleotide depletion and
mitochondrial denergization during the stress imposed by
either oxygen- or nitrogen-reactive species. Indeed, overex-
pression of rat liver MAT cDNA in Chinese hamster ovary
cells led to ATP and nicotinamide adenine dinucleotide
depletion and increased the sensitivity of the cells to oxida-
tive stress.10 This mechanism would resemble that demon-
strated in hemoglobin and cardiac calcium release channel,
in which S-nitrosylation regulates the activity of these pro-
teins.34,35
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